Centene Corporation (LON:0HVB)
London · Delayed Price · Currency is GBP · Price in USD 39.87
+0.32 (0.81%)
Dec 22, 2025, 5:02 PM BST
Centene Market Cap
Centene has a market cap or net worth of 14.34 billion as of December 22, 2025. Its market cap has decreased by -39.57% in one year.
Market Cap
14.34B
Enterprise Value
14.81B
Revenue
124.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
39.87
Market Cap Chart
Since December 13, 2001, Centene's market cap has increased from 10.73M to 14.34B, an increase of 133,572.09%. That is a compound annual growth rate of 34.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 14.34B | -41.30% |
| Dec 31, 2024 | 24.43B | -21.50% |
| Dec 29, 2023 | 31.12B | -19.25% |
| Dec 30, 2022 | 38.54B | 8.54% |
| Dec 31, 2021 | 35.51B | 39.29% |
| Dec 31, 2020 | 25.49B | 29.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.02B |
| GSK plc | 73.11B |
| Haleon | 33.29B |
| Smith & Nephew | 10.48B |
| Convatec Group | 4.72B |
| Hikma Pharmaceuticals | 3.35B |
| HUTCHMED (China) | 1.71B |
| Genus | 1.71B |